Trial intelligence / Profile preview

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Endometriosis and/or Adenomyosis

NCT04356664Phase 3Recruiting

Sponsor
Hôpital Foch
Start
Mar 2021
Primary completion
Jun 2026
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of triptorelin in endometriosis, adenomyosis, infertility, sponsored by Hôpital Foch. Started Mar 2021; status: recruiting.

02

Drugs

triptorelin
03

Conditions

endometriosisadenomyosisinfertility

Beyond the preview

Go deeper on NCT04356664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04356664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call